Skip to content

JAMA

JAMA is a peer-reviewed medical journal published by the American Medical Association, covering clinical research, reviews, and health policy.

Known aliases

  • JAMA
  • JAMA Network
  • JAMA Viewpoint
  • Journal of the American Medical Association

Current stories

scienceOne report1 publisher

In one donated brain, tau stayed sparse where aducanumab had cleared amyloid

Penn researchers found little tau in the parts of one donated brain where aducanumab had cleared amyloid plaques. The finding comes from one patient, so it fits a lasting protective effect of amyloid removal but cannot establish one.

Publishers:sciencedaily.com

Reality

Evidence35
Adoption
Not scored
Hype gap+20
Incentives
Not scored
Confidence50
scienceOne report1 publisher

Follow-up studies largely fail to reproduce the 1999 finding that strained caregivers die sooner

Naomi Eisenberger and colleagues report that a 1999 finding of 63 percent higher mortality in strained caregivers has mostly failed to replicate. The correction matters to some 63 million US adults who give care, a role popular wisdom says can shave years off a life.

Publishers:sciencenews.org

Reality

Evidence55
Adoption
Not scored
Hype gap+10
Incentives
Not scored
Confidence50
scienceOne report1 publisher

JAMA tally puts race-day cardiac death near one in 500,000 US distance-race finishes

Runners died at the Milwaukee and Cardiff half marathons on Oct. 4, 2026, against a JAMA count of 59 deaths in 29.3 million US race finishes. That is about one per 500,000 finishes, and the advice attached is to stop for chest pain or faintness even with the finish in sight.

Reality

Evidence55
Adoption
Not scored
Hype gap0
Incentives
Not scored
Confidence50
scienceOne report1 publisher

US measles cases outpace the whole of 2025 by 52% with months left to count

US measles cases reached 3,471 by Sept. 17, about 52% more than in all of 2025, CDC figures show. New AAP guidance prepares clinicians for babies infected before birth, whose risk estimates rest on limited research.

Reality

Evidence62
Adoption
Not scored
Hype gap+15
Incentives
Not scored
Confidence60
scienceOne report1 publisher

A public health consultant argues vaccine advocacy needs a party more than another PDF chart

Writing in STAT, a communications consultant compares September's flu, Covid and RSV safety review with the 1955 polio announcement and concludes the movement forgot how to celebrate, on the strength of two episodes and no comparison group.

Publishers:statnews.com

Reality

Evidence32
Adoption
Not scored
Hype gap+34
Incentives66
Confidence54
scienceOne report1 publisher

WTC Health Program reports 26% to 64% lower cancer mortality in enrolled responders

Scientists affiliated with the program set out in JAMA what 25 years of monitoring has taught them about multimorbidity in the 9/11 cohort. Their strongest survival number rests on an unmatched comparison.

Publishers:genengnews.com

Reality

Evidence52
Adoption72
Hype gap+22
Incentives70
Confidence55
leadershipOne report1 publisher

A ten-point drop in patient openness undercuts the 2030 case for AI clinicians

The JAMA argument for replacing physicians rests on single-task simulations. Ohio State's January survey put public openness to AI in healthcare at 42%. That is the number any rollout plan has to clear.

Publishers:forbes.com

Reality

Evidence33
Adoption36
Hype gap+44
Incentives58
Confidence41
productOne report1 publisher

Emanuel and Khosla argue the physician in the loop now degrades AI performance

Their JAMA review reads two years of literature and puts autonomous AI ahead of physician-AI hybrids by 2030, while the AMA's chief executive says some of those studies are simulations that do not all point that way.

Publishers:wired.com

Reality

Evidence48
Adoption21
Hype gap+46
Incentives76
Confidence52
scienceOne report1 publisher

Coronary calcium earns one narrow job: breaking statin ties in the 3-to-10 percent band

Two August analyses of the same cohort found calcium scores only change predictions at borderline and intermediate PREVENT risk. CTs ordered for other reasons did the job as well.

Publishers:statnews.com

Reality

Evidence62
Adoption44
Hype gap+12
Incentives52
Confidence55
scienceOne report1 publisher

An oral GLP-1 moves the bottleneck from the cold chain to the prescription pad

Orforglipron's approval takes peptide manufacturing and refrigeration off the constraint list. What replaces them is prescribing capacity in primary care and daily adherence.

Reality

Evidence42
Adoption48
Hype gap+28
Incentives58
Confidence40